4,573 articles in this topic
Key cancer findings: renaming low-risk prostate cancer could save 2,400 lives yearly, tamoxifen cuts breast cancer risk, and rural screening access worsens.
Arvinas' vepdegestrant becomes the first PROTAC to clear Phase 3 trials, targeting disease proteins for destruction rather than just blocking them.
New research links lacunar stroke to enlarged brain blood vessels, not artery plaque — explaining why aspirin often fails these patients.
An 8-hour feeding window extended median lifespan in male mice by 12%, though caloric restriction may explain part of the benefit.
Early data show sustained telomere lengthening in blood cells, while a new licensing deal advances a dystrophin therapy for Duchenne muscular dystrophy.
A renewed five-year partnership will accelerate neurodegenerative disease therapies, including a promising anti-tau antibody already in clinical trials.
BPM31510 improved walking, strength and fatigue in four children with primary CoQ10 deficiency, prompting FDA Phase 3 trial talks.
The Forever Healthy Foundation adds a transparent, AI-assisted peptide evidence library to help cut through hype and find real clinical signal.
A drug developed for ALS shows biological activity in Alzheimer's, suggesting shared mechanisms across neurodegenerative diseases.
Scientists engineer mammary organoids that secrete anticancer drugs while simultaneously regenerating functional breast tissue after surgery.
Japan's April 2026 revised guidelines now govern stem cell-based embryo models, marking a global regulatory milestone.
A biodegradable microneedle stent achieves sutureless intestinal anastomosis while releasing anti-inflammatory drugs triggered by local inflammation.
